海辰药业: 关联交易决策制度（2025年6月）

Core Viewpoint - The document outlines the decision-making system for related party transactions of Nanjing Haichen Pharmaceutical Co., Ltd, ensuring fairness, transparency, and protection of investors' rights, particularly for minority shareholders [1][2]. Group 1: Related Party Definition - Related parties include both legal entities and natural persons that have control or significant influence over the company [3][4]. - Legal entities are considered related if they are controlled directly or indirectly by the company or its major shareholders [4][5]. - Natural persons are considered related if they hold more than 5% of the company's shares or are part of the company's management [5][6]. Group 2: Related Party Transactions - Related party transactions involve the transfer of resources or obligations between the company and its related parties, including asset purchases, financial support, and management contracts [6][7]. - Certain transactions, such as cash subscriptions for securities, may be exempt from disclosure and approval processes [7][8]. Group 3: Decision-Making Procedures - The company must ensure that related party transactions do not harm the interests of non-related shareholders and must follow fair pricing principles [8][9]. - Related parties must abstain from voting on matters where they have a conflict of interest during board and shareholder meetings [9][10]. - Transactions exceeding a specified threshold must be evaluated by independent financial advisors and submitted for shareholder approval [10][11]. Group 4: Disclosure and Reporting - The company is required to disclose related party transactions in its annual and semi-annual reports, categorizing them appropriately [11][12]. - Any changes to ongoing related party agreements must be submitted for board or shareholder approval [12][13]. Group 5: Prohibitions and Restrictions - The company is prohibited from providing financial assistance to related parties, with specific exceptions for certain joint ventures [13][14]. - Guarantees provided to related parties must be disclosed and approved by the board and shareholders [14][15].